Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone acetonide to prevent proliferative vitreoretinopathy after open globe trauma surgery
2007-005138-35Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in Proliferative Vitreoretinopathy (PVR), open globe injury (OGI), sponsored by Moorfields Eye Hospital. Started Jan 2008; status: completed.
02
Drugs
triamcinolone
03
Conditions
Proliferative Vitreoretinopathy (PVR)open globe injury (OGI)
Beyond the preview
Go deeper on 2007-005138-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005138-35.